Refractory distal ulcerative colitis

Is proctocolectomy always necessary?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Refractory distal ulcerative colitis (RDUC) is defined as persistence of symptoms caused by endoscopically proven colonic inflammation located at the rectum or left colon despite oral/topical steroids and 5-ASA. RDUC affects a small subset of patients and is associated with chronic disabling symptoms and increased social/medical costs. Moreover, patients with long-standing ulcerative colitis (UC) carry an elevated risk of developing colorectal cancer and colonic mucosa high-grade dysplasia. Alternative medical strategies in steroid refractory disease are unlikely to provide durable remission in all patients, carry potential severe side effects and, as immunosuppressants, the risk of other neoplasms, and may increase the short-term complication rate when surgery is finally required. Restorative proctocolectomy with ileal pouch-anal anastomosis (RP-IPAA) allows the complete removal of the diseased rectum and colon, virtually eliminating the risk of malignant transformation and reestablishing intestinal continuity with continence preservation. Since the introduction of this surgical procedure, morbidity and mortality rates have been drastically reduced. Despite the still notable rate of surgical complications, long-term quality of life assessment has shown excellent results in nearly all patients who have undergone RP-IPAA, comparing well with the general population. Furthermore, when performed for distal UC, RP-IPAA produces similar surgical outcomes with respect to pancolitis. In conclusion, RP-IPAA should always be considered in patients with RDUC, and multidisciplinary counseling should provide patients clear information about the advantages of surgery and possible complications as well as the chance to achieve disease remission with medical therapy.

Original languageEnglish
Pages (from-to)110-115
Number of pages6
JournalDigestive Diseases
Volume32
DOIs
Publication statusPublished - Dec 25 2014

Fingerprint

Ulcerative Colitis
Restorative Proctocolectomy
Colonic Pouches
Rectum
Colon
Steroids
Immunosuppressive Agents
Counseling
Colorectal Neoplasms
Mucous Membrane
Quality of Life
Inflammation
Morbidity
Costs and Cost Analysis
Mortality
Population
Neoplasms

Keywords

  • Cancer risk
  • Ileal pouch-anal anastomosis
  • Medical therapy
  • Refractory distal ulcerative colitis
  • Restorative proctocolectomy

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Refractory distal ulcerative colitis : Is proctocolectomy always necessary? / Carvello, Michele; Montorsi, Marco; Spinelli, Antonino.

In: Digestive Diseases, Vol. 32, 25.12.2014, p. 110-115.

Research output: Contribution to journalArticle

@article{e8348c93f5b649a697ba663a7cb62df5,
title = "Refractory distal ulcerative colitis: Is proctocolectomy always necessary?",
abstract = "Refractory distal ulcerative colitis (RDUC) is defined as persistence of symptoms caused by endoscopically proven colonic inflammation located at the rectum or left colon despite oral/topical steroids and 5-ASA. RDUC affects a small subset of patients and is associated with chronic disabling symptoms and increased social/medical costs. Moreover, patients with long-standing ulcerative colitis (UC) carry an elevated risk of developing colorectal cancer and colonic mucosa high-grade dysplasia. Alternative medical strategies in steroid refractory disease are unlikely to provide durable remission in all patients, carry potential severe side effects and, as immunosuppressants, the risk of other neoplasms, and may increase the short-term complication rate when surgery is finally required. Restorative proctocolectomy with ileal pouch-anal anastomosis (RP-IPAA) allows the complete removal of the diseased rectum and colon, virtually eliminating the risk of malignant transformation and reestablishing intestinal continuity with continence preservation. Since the introduction of this surgical procedure, morbidity and mortality rates have been drastically reduced. Despite the still notable rate of surgical complications, long-term quality of life assessment has shown excellent results in nearly all patients who have undergone RP-IPAA, comparing well with the general population. Furthermore, when performed for distal UC, RP-IPAA produces similar surgical outcomes with respect to pancolitis. In conclusion, RP-IPAA should always be considered in patients with RDUC, and multidisciplinary counseling should provide patients clear information about the advantages of surgery and possible complications as well as the chance to achieve disease remission with medical therapy.",
keywords = "Cancer risk, Ileal pouch-anal anastomosis, Medical therapy, Refractory distal ulcerative colitis, Restorative proctocolectomy",
author = "Michele Carvello and Marco Montorsi and Antonino Spinelli",
year = "2014",
month = "12",
day = "25",
doi = "10.1159/000367860",
language = "English",
volume = "32",
pages = "110--115",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Refractory distal ulcerative colitis

T2 - Is proctocolectomy always necessary?

AU - Carvello, Michele

AU - Montorsi, Marco

AU - Spinelli, Antonino

PY - 2014/12/25

Y1 - 2014/12/25

N2 - Refractory distal ulcerative colitis (RDUC) is defined as persistence of symptoms caused by endoscopically proven colonic inflammation located at the rectum or left colon despite oral/topical steroids and 5-ASA. RDUC affects a small subset of patients and is associated with chronic disabling symptoms and increased social/medical costs. Moreover, patients with long-standing ulcerative colitis (UC) carry an elevated risk of developing colorectal cancer and colonic mucosa high-grade dysplasia. Alternative medical strategies in steroid refractory disease are unlikely to provide durable remission in all patients, carry potential severe side effects and, as immunosuppressants, the risk of other neoplasms, and may increase the short-term complication rate when surgery is finally required. Restorative proctocolectomy with ileal pouch-anal anastomosis (RP-IPAA) allows the complete removal of the diseased rectum and colon, virtually eliminating the risk of malignant transformation and reestablishing intestinal continuity with continence preservation. Since the introduction of this surgical procedure, morbidity and mortality rates have been drastically reduced. Despite the still notable rate of surgical complications, long-term quality of life assessment has shown excellent results in nearly all patients who have undergone RP-IPAA, comparing well with the general population. Furthermore, when performed for distal UC, RP-IPAA produces similar surgical outcomes with respect to pancolitis. In conclusion, RP-IPAA should always be considered in patients with RDUC, and multidisciplinary counseling should provide patients clear information about the advantages of surgery and possible complications as well as the chance to achieve disease remission with medical therapy.

AB - Refractory distal ulcerative colitis (RDUC) is defined as persistence of symptoms caused by endoscopically proven colonic inflammation located at the rectum or left colon despite oral/topical steroids and 5-ASA. RDUC affects a small subset of patients and is associated with chronic disabling symptoms and increased social/medical costs. Moreover, patients with long-standing ulcerative colitis (UC) carry an elevated risk of developing colorectal cancer and colonic mucosa high-grade dysplasia. Alternative medical strategies in steroid refractory disease are unlikely to provide durable remission in all patients, carry potential severe side effects and, as immunosuppressants, the risk of other neoplasms, and may increase the short-term complication rate when surgery is finally required. Restorative proctocolectomy with ileal pouch-anal anastomosis (RP-IPAA) allows the complete removal of the diseased rectum and colon, virtually eliminating the risk of malignant transformation and reestablishing intestinal continuity with continence preservation. Since the introduction of this surgical procedure, morbidity and mortality rates have been drastically reduced. Despite the still notable rate of surgical complications, long-term quality of life assessment has shown excellent results in nearly all patients who have undergone RP-IPAA, comparing well with the general population. Furthermore, when performed for distal UC, RP-IPAA produces similar surgical outcomes with respect to pancolitis. In conclusion, RP-IPAA should always be considered in patients with RDUC, and multidisciplinary counseling should provide patients clear information about the advantages of surgery and possible complications as well as the chance to achieve disease remission with medical therapy.

KW - Cancer risk

KW - Ileal pouch-anal anastomosis

KW - Medical therapy

KW - Refractory distal ulcerative colitis

KW - Restorative proctocolectomy

UR - http://www.scopus.com/inward/record.url?scp=84919783353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919783353&partnerID=8YFLogxK

U2 - 10.1159/000367860

DO - 10.1159/000367860

M3 - Article

VL - 32

SP - 110

EP - 115

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

ER -